These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27095050)

  • 61. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
    Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Parotid gland as the main site of metastasis of the cutaneous squamous cell carcinoma of the head].
    Teymoortash A
    Laryngorhinootologie; 2007 Oct; 86(10):699-704. PubMed ID: 17879900
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
    Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
    JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
    Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
    J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells.
    Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M
    J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.
    Gómez-de Castro C; Santos-Juanes R; Nuñez-Gómez B; Fernández-Vega I; Vivanco B; Fernández-Velasco A; Reyes-García S; Carrero-Martín J; García-Pedrero JM; Rodrigo JP; González-Vela MDC; Santos-Juanes J; Galache C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673889
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Investigating proteome changes between primary and metastatic cutaneous squamous cell carcinoma using SWATH mass spectrometry.
    Azimi A; Lo K; Kim J; Fernandez-Penas P
    J Dermatol Sci; 2020 Aug; 99(2):119-127. PubMed ID: 32651104
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors.
    Brougham ND; Dennett ER; Cameron R; Tan ST
    J Surg Oncol; 2012 Dec; 106(7):811-5. PubMed ID: 22592943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
    Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
    Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck.
    García-Pedrero JM; Martínez-Camblor P; Diaz-Coto S; Munguia-Calzada P; Vallina-Alvarez A; Vazquez-Lopez F; Rodrigo JP; Santos-Juanes J
    J Am Acad Dermatol; 2017 Sep; 77(3):527-533. PubMed ID: 28716437
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence of cutaneous squamous cell carcinoma in a New Zealand population of chronic lymphocytic leukaemia patients.
    Hock BD; McIntosh ND; McKenzie JL; Pearson JF; Simcock JW; MacPherson SA
    Intern Med J; 2016 Dec; 46(12):1414-1421. PubMed ID: 27664975
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma.
    Maly CJ; Cumsky HJL; Costello CM; Schmidt JE; Butterfield RJ; Zhang N; DiCaudo DJ; Nelson SA; Smith ML; Ochoa SA; Baum CL; Nagel TH; Pittelkow MR; Sekulic A; Mangold AR
    J Am Acad Dermatol; 2020 Apr; 82(4):846-853. PubMed ID: 31437542
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
    Kendi AT; Magliocca KR; Corey A; Galt JR; Switchenko J; Wadsworth JT; El-Deiry MW; Schuster DM; Saba NF; Hudgins PA
    AJR Am J Roentgenol; 2016 Sep; 207(3):635-40. PubMed ID: 27276388
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma.
    Gurney B; Newlands C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):294-300. PubMed ID: 24559975
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Facial squamous carcinoma with parotid metastasis--closure with cheek-neck rotation.
    Anonsen C; Patterson HC
    J Otolaryngol; 1984 Jun; 13(3):137-40. PubMed ID: 6544827
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk factors for recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery: A retrospective review of 237 Asian patients.
    Oh Y; Kim J; Zheng Z; Kim SK; Chung KY; Roh MR
    J Dermatol; 2020 Jan; 47(1):72-77. PubMed ID: 31674043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predicting lymph node metastases in cutaneous squamous cell carcinoma: use of a morphological scoring system.
    Agar NJ; Kirton C; Patel RS; Martin RC; Angelo N; Emanuel PO
    N Z Med J; 2015 Mar; 128(1411):59-67. PubMed ID: 25820504
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Intra-parotid lymph node metastasis of malignant skin neoplasms of the head].
    Zanetti D; Renaldini G; Peretti G; Antonelli AR
    Acta Otorhinolaryngol Ital; 1989; 9(4):381-90. PubMed ID: 2694753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma.
    Wysong A; Newman JG; Covington KR; Kurley SJ; Ibrahim SF; Farberg AS; Bar A; Cleaver NJ; Somani AK; Panther D; Brodland DG; Zitelli J; Toyohara J; Maher IA; Xia Y; Bibee K; Griego R; Rigel DS; Meldi Plasseraud K; Estrada S; Sholl LM; Johnson C; Cook RW; Schmults CD; Arron ST
    J Am Acad Dermatol; 2021 Feb; 84(2):361-369. PubMed ID: 32344066
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
    Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
    J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.